Annual report
3079.TEDINET S100W6AB
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Amended by S100W7ZJ (2025-06-27).
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥45.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥47.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥45.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥41.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥537m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥653m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥543m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥663m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥538m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥376m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥410m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥173m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥936m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥863m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥572m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥25.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥22.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥23.6bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥22.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥16.4bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥13.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.1bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥7.1bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.5bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.5bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥726m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥423m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥632m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥397m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥477m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥524m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥312m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥245m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥235m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥274m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥39.2 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.58 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.21 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.56 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.6 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.04 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.33 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.5 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥871.63 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥880.72 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥894.19 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥828.27 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥767.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.5% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,780,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 334 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 316 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 319 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 328 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 330 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 17
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Arrhythmia Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥42.5bn |
| Arrhythmia Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥42.5bn |
| Ischemia Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| Ischemia Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥3.2bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥45.7bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥45.7bn |
| Total Of Reportable Segments And Otherssegment total | employees | at 2025-03-31 | 334 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥4.1bn |
| Arrhythmia Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥39.3bn |
| Arrhythmia Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥39.3bn |
| Ischemia Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| Ischemia Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥41.8bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥41.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,017
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1YearDuration_NonConsolidatedMember | -396557000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration_NonConsolidatedMember | -631931000 | JPY |
| Repayments of finance lease obligations fin cf | Prior1YearDuration_NonConsolidatedMember | -1853000 | JPY |
| Repayments of finance lease obligations fin cf | CurrentYearDuration_NonConsolidatedMember | -2403000 | JPY |
| Proceeds from disposal of treasury stock fin cf | Prior1YearDuration_NonConsolidatedMember | 1678000 | JPY |
| Proceeds from disposal of treasury stock fin cf | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Cash dividends paid fin cf | Prior1YearDuration_NonConsolidatedMember | -312135000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration_NonConsolidatedMember | -521684000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration_NonConsolidatedMember | -312310000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration_NonConsolidatedMember | -524088000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | 6617000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | -407000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | -1124818000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | -430882000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 8614223000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 7489404000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 7489404000 | JPY |
| Cash and cash equivalents | CurrentYearInstant_NonConsolidatedMember | 7058521000 | JPY |
| Write downs of inventories | Prior1YearDuration_NonConsolidatedMember | -55298000 | JPY |
| Write downs of inventories | CurrentYearDuration_NonConsolidatedMember | 4449000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 1459150000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 1572986000 | JPY |
| Bonuses and provision for bonuses sga | Prior1YearDuration_NonConsolidatedMember | 516735000 | JPY |
| Bonuses and provision for bonuses sga | CurrentYearDuration_NonConsolidatedMember | 595159000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 78889000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 73666000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 147595000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 172839000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 30991000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 12224000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentMember | 39305978000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentMember | 2456059000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 41762037000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4089037000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember | 45851074000 | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentMember | 39305978000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentMember | 2456059000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 41762037000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4089037000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember | 45851074000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentMember | 3968281000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentMember | 329349000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 4297630000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 466938000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember | 4764568000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |